• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型抗生素物质:西索米星的体外细菌学研究

In vitro bacteriological study of a new antibiotic substance: sisomicin.

作者信息

Jedlicková Z, Sulová J

出版信息

Zentralbl Bakteriol Orig A. 1975 Jan;230(1):104-11.

PMID:809943
Abstract

Effects of a new antimicrobial agent sisomicin on microorganisms isolated from pathologic material (Pseudomonas aeruginosa, Staphylococcus aureus, Serratia marcescens, Klebsiella pneumoniae, Salmonella spp., Streptococcus pyogenes-B, Citrobacter Freundii) were studied. The results obtained were compared with another two aminoglycoside antibiotics - gentamicin and tobramycin. All three antibiotics were found to be very effective in vitro; their effect was enhanced by addition of an antibiotic of the penicillin group (carbenicillin, suncillin) or an antibiotic of the tetracyklin series (oxytetracyklin, doxycyklin). All three preparations were tested on 26 Mycobacterium tuberculosis strains. Tobramycin inhibited growth of 22 strains and thus presented the highest level of efficiency among these deoxystreptamin preparations.

摘要

研究了一种新型抗菌剂西索米星对从病理材料中分离出的微生物(铜绿假单胞菌、金黄色葡萄球菌、粘质沙雷氏菌、肺炎克雷伯菌、沙门氏菌属、化脓性链球菌B群、弗氏柠檬酸杆菌)的作用。将所得结果与另外两种氨基糖苷类抗生素——庆大霉素和妥布霉素进行了比较。发现所有三种抗生素在体外都非常有效;通过添加青霉素类抗生素(羧苄青霉素、磺苄青霉素)或四环素类抗生素(土霉素、强力霉素)可增强它们的作用。对26株结核分枝杆菌菌株测试了所有三种制剂。妥布霉素抑制了22株菌株的生长,因此在这些脱氧链霉胺制剂中表现出最高的效率水平。

相似文献

1
In vitro bacteriological study of a new antibiotic substance: sisomicin.一种新型抗生素物质:西索米星的体外细菌学研究
Zentralbl Bakteriol Orig A. 1975 Jan;230(1):104-11.
2
Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.奈替米星与庆大霉素、西索米星、妥布霉素和阿米卡星相比的抗菌活性及其耐药模式。
Arzneimittelforschung. 1980;30(3):491-5.
3
[Antibacterial activity of sisomicin in comparison with gentamicin].西索米星与庆大霉素相比的抗菌活性
Arzneimittelforschung. 1976;26(5):772-8.
4
[Sisomicin versus gentamicin. A comparison of antibacterial and pharmacokinetic properties (author's transl)].西索米星与庆大霉素。抗菌及药代动力学特性比较(作者译)
Dtsch Med Wochenschr. 1976 Aug 27;101(35):1277-84. doi: 10.1055/s-0028-1104256.
5
[Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].庆大霉素、妥布霉素、阿米卡星和西索米星的体外抗菌活性(作者译)
Lijec Vjesn. 1978 Nov;100(11):708-10.
6
Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.耐庆大霉素铜绿假单胞菌的药敏性
Mayo Clin Proc. 1977 Dec;52(12):802-5.
7
Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.美洛西林:一种新型酰脲类青霉素。抗菌活性及与四种氨基糖苷类抗生素的联合效应。
Chemotherapy. 1978;24(3):134-42. doi: 10.1159/000237772.
8
R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.来自单一临床来源的沙雷氏菌、克雷伯氏菌和大肠杆菌菌株中编码庆大霉素、妥布霉素和羧苄青霉素抗性的R质粒
Chemotherapy. 1977;23(1):37-43. doi: 10.1159/000221969.
9
[Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].西索米星的抗菌效能。I:西索米星与庆大霉素、妥布霉素、阿米卡星和卡那霉素相比的体外活性(作者译)
Infection. 1976;4(2):35-41. doi: 10.1007/BF01638346.
10
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.新型氨基糖苷类抗生素和羧苄青霉素单独及联合使用时对庆大霉素耐药铜绿假单胞菌的活性。
Antimicrob Agents Chemother. 1976 Sep;10(3):399-401. doi: 10.1128/AAC.10.3.399.